Morar Bharti, Gresham David, Angelicheva Dora, Tournev Ivailo, Gooding Rebecca, Guergueltcheva Velina, Schmidt Carolin, Abicht Angela, Lochmuller Hanns, Tordai Attila, Kalmar Lajos, Nagy Melinda, Karcagi Veronika, Jeanpierre Marc, Herczegfalvi Agnes, Beeson David, Venkataraman Viswanathan, Warwick Carter Kim, Reeve Jeff, de Pablo Rosario, Kucinskas Vaidutis, Kalaydjieva Luba
Laboratory of Molecular Genetics, Western Australian Institute for Medical Research and UWA Centre for Medical Research, University of Western Australia, Perth, Australia.
Am J Hum Genet. 2004 Oct;75(4):596-609. doi: 10.1086/424759. Epub 2004 Aug 20.
The 8-10 million European Roma/Gypsies are a founder population of common origins that has subsequently split into multiple socially divergent and geographically dispersed Gypsy groups. Unlike other founder populations, whose genealogy has been extensively documented, the demographic history of the Gypsies is not fully understood and, given the lack of written records, has to be inferred from current genetic data. In this study, we have used five disease loci harboring private Gypsy mutations to examine some missing historical parameters and current structure. We analyzed the frequency distribution of the five mutations in 832-1,363 unrelated controls, representing 14 Gypsy populations, and the diversification of chromosomal haplotypes in 501 members of affected families. Sharing of mutations and high carrier rates supported a strong founder effect, and the identity of the congenital myasthenia 1267delG mutation in Gypsy and Indian/Pakistani chromosomes provided the best evidence yet of the Indian origins of the Gypsies. However, dramatic differences in mutation frequencies and haplotype divergence and very limited haplotype sharing pointed to strong internal differentiation and characterized the Gypsies as a founder population comprising multiple subisolates. Using disease haplotype coalescence times at the different loci, we estimated that the entire Gypsy population was founded approximately 32-40 generations ago, with secondary and tertiary founder events occurring approximately 16-25 generations ago. The existence of multiple subisolates, with endogamy maintained to the present day, suggests a general approach to complex disorders in which initial gene mapping could be performed in large families from a single Gypsy group, whereas fine mapping would rely on the informed sampling of the divergent subisolates and searching for the shared genomic region that displays the strongest linkage disequilibrium with the disease.
欧洲800万至1000万罗姆人/吉普赛人是一个有着共同起源的奠基人群体,后来分化成多个社会差异较大且地理分布分散的吉普赛群体。与其他族谱有详尽记录的奠基人群体不同,吉普赛人的人口历史尚未完全明晰,鉴于缺乏书面记录,只能从当前的基因数据中推断。在本研究中,我们利用了五个携带吉普赛人特有突变的疾病基因座,来探究一些缺失的历史参数和当前结构。我们分析了14个吉普赛群体中832至1363名无关对照个体的五个突变的频率分布,以及501名患病家庭成员染色体单倍型的多样性。突变的共享和高携带率支持了强烈的奠基者效应,吉普赛人和印度/巴基斯坦染色体上先天性肌无力1267delG突变的一致性,提供了迄今关于吉普赛人起源于印度的最佳证据。然而,突变频率和单倍型差异的巨大不同以及非常有限的单倍型共享,表明内部存在强烈分化,这使得吉普赛人成为一个由多个亚隔离群体组成的奠基人群体。利用不同基因座的疾病单倍型合并时间,我们估计整个吉普赛人群体大约在32至40代之前形成,二级和三级奠基事件大约发生在16至25代之前。多个亚隔离群体的存在以及至今仍保持的族内通婚现象,提示了一种针对复杂疾病的通用方法,即最初的基因定位可在来自单个吉普赛群体的大家庭中进行,而精细定位则依赖于对不同亚隔离群体进行明智抽样,并寻找与疾病显示最强连锁不平衡的共享基因组区域。